首页 > 最新文献

Alzheimer's & Dementia最新文献

英文 中文
Eating and swallowing care disparities in persons with dementia: A conceptual framework
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-26 DOI: 10.1002/alz.70028
Raele Donetha Loy, Nicole Rogus-Pulia, Fred Ketchum, Michelle Troche, Anaïs Rameau, Harrison N. Jones, Luis Riquelme, Andrea Gilmore-Bykovskyi, Manish N. Shah, Amy Kind

INTRODUCTION

Eating and swallowing difficulties are prevalent and distressing among persons living with dementia (PLWD). These challenges may be especially burdensome for PLWD in lower-resourced settings, where environmental factors such as social support, health-care infrastructure, and food access are critical for meeting quality standards of eating and swallowing care. However, clinical practices and research methods have not sufficiently focused on the lived environment to promote high-quality, socially and culturally aligned management approaches.

METHODS

To address this gap, we developed a conceptual framework informed by the literature, grounded in ecological systems and fundamental cause theories, and refined through iterative discussion.

RESULTS

Our framework highlights individual-, system-, and community-level factors and resources influencing person-centered eating and swallowing care for PLWD. It identifies areas at risk for inequitable care along the swallowing management continuum.

DISCUSSION

We propose future research areas to help health-care providers reconcile the demands of eating and swallowing care with the lived realities of PLWD.

Highlights

  • There are eating/swallowing care disparities among persons living with dementia.
  • We introduce a conceptual framework applying social and structural determinants of health to eating/swallowing care.
  • We also recommend areas to address disparities and improve eating/swallowing care.
{"title":"Eating and swallowing care disparities in persons with dementia: A conceptual framework","authors":"Raele Donetha Loy,&nbsp;Nicole Rogus-Pulia,&nbsp;Fred Ketchum,&nbsp;Michelle Troche,&nbsp;Anaïs Rameau,&nbsp;Harrison N. Jones,&nbsp;Luis Riquelme,&nbsp;Andrea Gilmore-Bykovskyi,&nbsp;Manish N. Shah,&nbsp;Amy Kind","doi":"10.1002/alz.70028","DOIUrl":"https://doi.org/10.1002/alz.70028","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> INTRODUCTION</h3>\u0000 \u0000 <p>Eating and swallowing difficulties are prevalent and distressing among persons living with dementia (PLWD). These challenges may be especially burdensome for PLWD in lower-resourced settings, where environmental factors such as social support, health-care infrastructure, and food access are critical for meeting quality standards of eating and swallowing care. However, clinical practices and research methods have not sufficiently focused on the lived environment to promote high-quality, socially and culturally aligned management approaches.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> METHODS</h3>\u0000 \u0000 <p>To address this gap, we developed a conceptual framework informed by the literature, grounded in ecological systems and fundamental cause theories, and refined through iterative discussion.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> RESULTS</h3>\u0000 \u0000 <p>Our framework highlights individual-, system-, and community-level factors and resources influencing person-centered eating and swallowing care for PLWD. It identifies areas at risk for inequitable care along the swallowing management continuum.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> DISCUSSION</h3>\u0000 \u0000 <p>We propose future research areas to help health-care providers reconcile the demands of eating and swallowing care with the lived realities of PLWD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Highlights</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>There are eating/swallowing care disparities among persons living with dementia.</li>\u0000 \u0000 <li>We introduce a conceptual framework applying social and structural determinants of health to eating/swallowing care.</li>\u0000 \u0000 <li>We also recommend areas to address disparities and improve eating/swallowing care.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.70028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143490019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individual and joint associations between sleep duration and physical activity with cognitive function: a longitudinal analysis among middle-aged and older adults in China
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-26 DOI: 10.1002/alz.70049
Zhiyi Zhang
<p>I read the article written by Hongwei Liu and his colleagues with interest, and I would like to commend the author for conducting such a comprehensive longitudinal study, examining the relationship between sleep time, physical activity, and cognitive function among middle-aged and elderly people in China.<span><sup>1</sup></span> The research provides valuable insights into the potential effects of lifestyle factors, specifically sleep and physical activity, on cognitive aging. However, I would like to offer several suggestions and comments for consideration.</p><p>First, although the study considered sleep duration, it did not delve into the impact of sleep quality.<span><sup>2, 3</sup></span> Research has shown that sleep quality has a significant impact on cognitive function, and analyzing solely based on sleep duration may overlook other important factors that affect cognitive function, such as sleep interruption, lack of deep sleep, etc., which may have an impact on cognition and, thus, affect the accuracy of research results.<span><sup>4</sup></span></p><p>Although this study employed lagged time series models to examine causal relationships, the possibility of reverse causation cannot be completely ruled out, particularly since early-stage cognitive decline may influence both sleep patterns and physical activity levels.<span><sup>5</sup></span> Specifically, deteriorating cognitive function could alter individuals' sleep habits and physical activity behaviors, making it challenging to fully disentangle the direction of causality. Future research should implement methodological approaches that minimize the potential impact of reverse causation to ensure greater validity of findings.<span><sup>6-8</sup></span></p><p>While this study thoroughly examined the relationships between sleep and physical activity, it may not have adequately addressed the potential non-linear effects of these variables. For instance, moderate physical activity might enhance cognitive function, whereas excessive physical activity could potentially yield adverse effects.<span><sup>9</sup></span> The analyses conducted in this study may not have fully captured such non-linear relationships. Furthermore, the lack of detailed categorization of physical activity types and intensities represents another limitation, as different forms of exercise (such as aerobic exercise and strength training) may differentially impact cognitive function, potentially affecting the precision of our findings.<span><sup>10</sup></span></p><p>Based on our findings, we propose implementing a three-tiered response system for cognitive health management. The first tier focuses on broad public health education, promoting awareness of cognitive health through campaigns that emphasize the importance of proper sleep habits and appropriate physical activity levels. The second tier targets high-risk populations, such as elderly individuals and those with family history of cognitive decline, providing
{"title":"Individual and joint associations between sleep duration and physical activity with cognitive function: a longitudinal analysis among middle-aged and older adults in China","authors":"Zhiyi Zhang","doi":"10.1002/alz.70049","DOIUrl":"https://doi.org/10.1002/alz.70049","url":null,"abstract":"&lt;p&gt;I read the article written by Hongwei Liu and his colleagues with interest, and I would like to commend the author for conducting such a comprehensive longitudinal study, examining the relationship between sleep time, physical activity, and cognitive function among middle-aged and elderly people in China.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; The research provides valuable insights into the potential effects of lifestyle factors, specifically sleep and physical activity, on cognitive aging. However, I would like to offer several suggestions and comments for consideration.&lt;/p&gt;&lt;p&gt;First, although the study considered sleep duration, it did not delve into the impact of sleep quality.&lt;span&gt;&lt;sup&gt;2, 3&lt;/sup&gt;&lt;/span&gt; Research has shown that sleep quality has a significant impact on cognitive function, and analyzing solely based on sleep duration may overlook other important factors that affect cognitive function, such as sleep interruption, lack of deep sleep, etc., which may have an impact on cognition and, thus, affect the accuracy of research results.&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Although this study employed lagged time series models to examine causal relationships, the possibility of reverse causation cannot be completely ruled out, particularly since early-stage cognitive decline may influence both sleep patterns and physical activity levels.&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; Specifically, deteriorating cognitive function could alter individuals' sleep habits and physical activity behaviors, making it challenging to fully disentangle the direction of causality. Future research should implement methodological approaches that minimize the potential impact of reverse causation to ensure greater validity of findings.&lt;span&gt;&lt;sup&gt;6-8&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;While this study thoroughly examined the relationships between sleep and physical activity, it may not have adequately addressed the potential non-linear effects of these variables. For instance, moderate physical activity might enhance cognitive function, whereas excessive physical activity could potentially yield adverse effects.&lt;span&gt;&lt;sup&gt;9&lt;/sup&gt;&lt;/span&gt; The analyses conducted in this study may not have fully captured such non-linear relationships. Furthermore, the lack of detailed categorization of physical activity types and intensities represents another limitation, as different forms of exercise (such as aerobic exercise and strength training) may differentially impact cognitive function, potentially affecting the precision of our findings.&lt;span&gt;&lt;sup&gt;10&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Based on our findings, we propose implementing a three-tiered response system for cognitive health management. The first tier focuses on broad public health education, promoting awareness of cognitive health through campaigns that emphasize the importance of proper sleep habits and appropriate physical activity levels. The second tier targets high-risk populations, such as elderly individuals and those with family history of cognitive decline, providing","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.70049","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143490035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Education and midlife cognitive functioning: Evidence from the High School and Beyond cohort 教育与中年认知功能:高中及高中以上组群的证据
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-26 DOI: 10.1002/alz.70015
Chandra Muller, Eric Grodsky, Adam M. Brickman, Jennifer J. Manly, Koit Hung, Michael J. Culbertson, John Robert Warren

INTRODUCTION

Educational attainment is associated with midlife cognitive functioning. However, degree attainment is the culmination of complex and unequal processes involving students’ backgrounds, the opportunities that schools provide them, and their performance within those schools─all of which may also shape midlife cognition. What do educational gradients in midlife cognition look like using a richer conceptualization and measures of “education?”

METHODS

We use data from High School and Beyond (HS&B:80)─a large, nationally representative sample of Americans followed from high school through age ∼60─to assess the role of education in stratifying midlife cognition.

RESULTS

High schools’ academic and socioeconomic environments predict midlife cognition primarily through their associations with their students’ academic performance. Student academic performance strongly predicts midlife cognition, partially through its association with degree attainment.

DISCUSSION

Inequalities in educational opportunities and in students’ performance in schools shape midlife cognition─even among students with the same attained degrees.

Highlights

  • Degree attainment predicts midlife cognitive functioning, but a large portion of that association is accounted for by students’ high school academic performance as measured by test scores, grades, and course completion.
  • High school contexts and learning opportunities predict midlife cognition mainly because they play a role in shaping students’ academic performance.
  • Understanding the potential benefits of education for later-life cognitive functioning requires attention to broader schooling processes and to students’ academic performance beyond degree attainment.
{"title":"Education and midlife cognitive functioning: Evidence from the High School and Beyond cohort","authors":"Chandra Muller,&nbsp;Eric Grodsky,&nbsp;Adam M. Brickman,&nbsp;Jennifer J. Manly,&nbsp;Koit Hung,&nbsp;Michael J. Culbertson,&nbsp;John Robert Warren","doi":"10.1002/alz.70015","DOIUrl":"https://doi.org/10.1002/alz.70015","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> INTRODUCTION</h3>\u0000 \u0000 <p>Educational attainment is associated with midlife cognitive functioning. However, degree attainment is the culmination of complex and unequal processes involving students’ backgrounds, the opportunities that schools provide them, and their performance within those schools─all of which may <i>also</i> shape midlife cognition. What do educational gradients in midlife cognition look like using a richer conceptualization and measures of “education?”</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> METHODS</h3>\u0000 \u0000 <p>We use data from High School and Beyond (HS&amp;B:80)─a large, nationally representative sample of Americans followed from high school through age ∼60─to assess the role of education in stratifying midlife cognition.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> RESULTS</h3>\u0000 \u0000 <p>High schools’ academic and socioeconomic environments predict midlife cognition primarily through their associations with their students’ academic performance. Student academic performance strongly predicts midlife cognition, partially through its association with degree attainment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> DISCUSSION</h3>\u0000 \u0000 <p>Inequalities in educational opportunities and in students’ performance in schools shape midlife cognition─even among students with the same attained degrees.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Highlights</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>Degree attainment predicts midlife cognitive functioning, but a large portion of that association is accounted for by students’ high school academic performance as measured by test scores, grades, and course completion.</li>\u0000 \u0000 <li>High school contexts and learning opportunities predict midlife cognition mainly because they play a role in shaping students’ academic performance.</li>\u0000 \u0000 <li>Understanding the potential benefits of education for later-life cognitive functioning requires attention to broader schooling processes and to students’ academic performance beyond degree attainment.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.70015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143490032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window 血浆 p-tau217 能识别认知功能正常、但在 10 年内会出现认知障碍的老年人
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-26 DOI: 10.1002/alz.14537
Yara Yakoub, Fernando Gonzalez-Ortiz, Nicholas J. Ashton, Christine Déry, Cherie Strikwerda-Brown, Frédéric St-Onge, Valentin Ourry, Michael Schöll, Maiya R. Geddes, Simon Ducharme, Maxime Montembeault, Pedro Rosa-Neto, Jean-Paul Soucy, John C. S. Breitner, Henrik Zetterberg, Kaj Blennow, Judes Poirier, Sylvia Villeneuve, PREVENT−AD Research Group

INTRODUCTION

We assessed the prognostic accuracy of plasma p-tau217 in predicting the progression to mild cognitive impairment (MCI) in cognitively unimpaired (CU) individuals over a mean follow-up of 5.65 years after plasma collection (range 1.01–10.47).

METHODS

We included 215 participants from the PREVENT−AD cohort with plasma Aβ42/40 and p-tau217, 159 with cerebrospinal fluid (CSF) Aβ42/40 and p-tau217, and 155 with 18F-NAV4694 and 18F-flortaucipir PET scans. MCI progression was determined by multidisciplinary consensus among memory experts blind to biomarker and genetic information.

RESULTS

Cox proportional hazard models indicated a greater progression rate in A+T+plasma and A−T+plasma compared to A−T−plasma individuals (HR = 7.81 [95% CI = 3.92 to 15.59] and HR = 4.25 [1.60–11.31] respectively). Similar results were found with CSF (HR = 3.63 [1.72–7.70]) and PET (HR = 9.30 [3.67–23.55]).

DISCUSSION

Plasma p-tau217 is a prognostic marker for identifying individuals who will develop cognitive impairment within ten years.

Highlights

  • Elevated plasma p-tau217 levels in CU individuals indicate future clinical progression.
  • Adding plasma Aβ42/40 status to p-tau markers did not improve the prediction to MCI.
  • All individuals with abnormal tau PET measured in a temporal meta-ROI progressed to MCI.
{"title":"Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window","authors":"Yara Yakoub,&nbsp;Fernando Gonzalez-Ortiz,&nbsp;Nicholas J. Ashton,&nbsp;Christine Déry,&nbsp;Cherie Strikwerda-Brown,&nbsp;Frédéric St-Onge,&nbsp;Valentin Ourry,&nbsp;Michael Schöll,&nbsp;Maiya R. Geddes,&nbsp;Simon Ducharme,&nbsp;Maxime Montembeault,&nbsp;Pedro Rosa-Neto,&nbsp;Jean-Paul Soucy,&nbsp;John C. S. Breitner,&nbsp;Henrik Zetterberg,&nbsp;Kaj Blennow,&nbsp;Judes Poirier,&nbsp;Sylvia Villeneuve,&nbsp;PREVENT−AD Research Group","doi":"10.1002/alz.14537","DOIUrl":"https://doi.org/10.1002/alz.14537","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> INTRODUCTION</h3>\u0000 \u0000 <p>We assessed the prognostic accuracy of plasma p-tau217 in predicting the progression to mild cognitive impairment (MCI) in cognitively unimpaired (CU) individuals over a mean follow-up of 5.65 years after plasma collection (range 1.01–10.47).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> METHODS</h3>\u0000 \u0000 <p>We included 215 participants from the PREVENT−AD cohort with plasma Aβ<sub>42/40</sub> and p-tau217, 159 with cerebrospinal fluid (CSF) Aβ<sub>42/40</sub> and p-tau217, and 155 with <sup>18</sup>F-NAV4694 and <sup>18</sup>F-flortaucipir PET scans. MCI progression was determined by multidisciplinary consensus among memory experts blind to biomarker and genetic information.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> RESULTS</h3>\u0000 \u0000 <p>Cox proportional hazard models indicated a greater progression rate in A+T+<sub>plasma</sub> and A−T+<sub>plasma</sub> compared to A−T−<sub>plasma</sub> individuals (HR = 7.81 [95% CI = 3.92 to 15.59] and HR = 4.25 [1.60–11.31] respectively). Similar results were found with CSF (HR = 3.63 [1.72–7.70]) and PET (HR = 9.30 [3.67–23.55]).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> DISCUSSION</h3>\u0000 \u0000 <p>Plasma p-tau217 is a prognostic marker for identifying individuals who will develop cognitive impairment within ten years.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Highlights</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>Elevated plasma p-tau217 levels in CU individuals indicate future clinical progression.</li>\u0000 \u0000 <li>Adding plasma Aβ<sub>42/40</sub> status to p-tau markers did not improve the prediction to MCI.</li>\u0000 \u0000 <li>All individuals with abnormal tau PET measured in a temporal meta-ROI progressed to MCI.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14537","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143490052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and factors associated with dementia in Lesotho: A cross-sectional, population-based study
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-25 DOI: 10.1002/alz.14614
Natalie E. Johnson, Jennifer M. Belus, Felix Gerber, Tristan T. Lee, Irene Ayakaka, Pearl Letsoela, Manthabiseng Molulela, Frédérique Chammartin, Alain Amstutz, Niklaus D. Labhardt

INTRODUCTION

Limited research has examined dementia prevalence and associated factors in Lesotho. This study investigates dementia prevalence and the associated factors in Lesotho.

METHODS

A survey in Lesotho included 1738 participants screened for dementia and potential associated factors with a focus on modifiable factors. Associations were evaluated using logistic regression models.

RESULTS

The median age was 66 years, with 54.83% women. The prevalence of dementia was 4.89%. Those with depressive symptoms (adjusted odds ratio [aOR]: 3.97, 95% confidence interval [CI]: 1.39–11.30), age ≥ 75 (aOR: 2.68, 95% CI: 1.42–5.04), and underweight (aOR 2.30, 95% CI: 1.23–4.29) had increased odds of dementia. Those with moderate (aOR: 0.32, 95% CI: 0.17–0.58) to high (aOR: 0.35, 95% CI: 0.16–0.77) physical activity and obesity (aOR: 0.30, 95% CI: 0.11–0.80) presented lower odds for dementia.

DISCUSSION

This study provides a contemporary estimate of dementia prevalence in Lesotho, highlighting an association with modifiable factors.

Highlights

  • In Lesotho there is a probable dementia prevalence of 4.89%, aligning with regional estimates for Africa.
  • Depression, older age, being underweight, and low physical activity were associated with increased odds of dementia.
  • Moderate to high physical activity and obesity were associated with lower dementia odds.
  • Further study of the association of dementia with potentially modifiable factors in low- and middle-income countries is warranted.
{"title":"Prevalence and factors associated with dementia in Lesotho: A cross-sectional, population-based study","authors":"Natalie E. Johnson,&nbsp;Jennifer M. Belus,&nbsp;Felix Gerber,&nbsp;Tristan T. Lee,&nbsp;Irene Ayakaka,&nbsp;Pearl Letsoela,&nbsp;Manthabiseng Molulela,&nbsp;Frédérique Chammartin,&nbsp;Alain Amstutz,&nbsp;Niklaus D. Labhardt","doi":"10.1002/alz.14614","DOIUrl":"https://doi.org/10.1002/alz.14614","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> INTRODUCTION</h3>\u0000 \u0000 <p>Limited research has examined dementia prevalence and associated factors in Lesotho. This study investigates dementia prevalence and the associated factors in Lesotho.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> METHODS</h3>\u0000 \u0000 <p>A survey in Lesotho included 1738 participants screened for dementia and potential associated factors with a focus on modifiable factors. Associations were evaluated using logistic regression models.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> RESULTS</h3>\u0000 \u0000 <p>The median age was 66 years, with 54.83% women. The prevalence of dementia was 4.89%. Those with depressive symptoms (adjusted odds ratio [aOR]: 3.97, 95% confidence interval [CI]: 1.39–11.30), age ≥ 75 (aOR: 2.68, 95% CI: 1.42–5.04), and underweight (aOR 2.30, 95% CI: 1.23–4.29) had increased odds of dementia. Those with moderate (aOR: 0.32, 95% CI: 0.17–0.58) to high (aOR: 0.35, 95% CI: 0.16–0.77) physical activity and obesity (aOR: 0.30, 95% CI: 0.11–0.80) presented lower odds for dementia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> DISCUSSION</h3>\u0000 \u0000 <p>This study provides a contemporary estimate of dementia prevalence in Lesotho, highlighting an association with modifiable factors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Highlights</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>In Lesotho there is a probable dementia prevalence of 4.89%, aligning with regional estimates for Africa.</li>\u0000 \u0000 <li>Depression, older age, being underweight, and low physical activity were associated with increased odds of dementia.</li>\u0000 \u0000 <li>Moderate to high physical activity and obesity were associated with lower dementia odds.</li>\u0000 \u0000 <li>Further study of the association of dementia with potentially modifiable factors in low- and middle-income countries is warranted.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14614","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143489872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanisms of comorbidity between Alzheimer's disease and pain
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-25 DOI: 10.1002/alz.14605
Kaifang Yao, Shenjun Wang, Zhifang Xu, Zezhi Fan, Zhihan Chen, Peng Jia, Shiwei Tu, Yangyang Liu, Xiaowei Lin, Yuan Xu, Yuxing Fang, Baomin Dou, Yi Guo

Clinical studies have revealed a significant correlation between pain and neurodegenerative diseases, particularly Alzheimer's disease (AD). However, due to cognitive and speech impairments, AD patients, especially those in moderate to severe stages, are often overlooked in pain management. The challenges in obtaining pain-related information from this population exacerbate the issue. Although recent clinical research has increasingly recognized the comorbidity of AD and pain, the pathological alterations and interactive mechanisms underlying this relationship remain inadequately explored. This review provides a comprehensive analysis of the clinical features and pathological mechanisms of AD with and without pain comorbidity. It examines underlying processes, including neuroinflammation, peripheral-central immune interactions, and neurotransmitter dynamics. Furthermore, it highlights current pain assessment and management strategies in AD patients. By offering a theoretical framework, this review aims to support the development of effective pain management approaches and serve as a reference for clinical interventions targeting AD-associated pain.

Highlights

  • The comorbidity between AD and CP encompasses multiple interrelated biological pathways, such as neurodegeneration and inflammatory responses.
  • The damage to neurons and synapses in AD patients influences the brain regions responsible for processing pain, thereby reducing the pain response.
  • Neuroinflammation plays a vital role in the development of both AD and CP. Enhanced inflammatory responses have an impact on the CNS and promote sensitization.
  • Common neurotransmitter alterations exist in the comorbidity of AD and CP, influencing cognition, emotion, and pain perception.
{"title":"Mechanisms of comorbidity between Alzheimer's disease and pain","authors":"Kaifang Yao,&nbsp;Shenjun Wang,&nbsp;Zhifang Xu,&nbsp;Zezhi Fan,&nbsp;Zhihan Chen,&nbsp;Peng Jia,&nbsp;Shiwei Tu,&nbsp;Yangyang Liu,&nbsp;Xiaowei Lin,&nbsp;Yuan Xu,&nbsp;Yuxing Fang,&nbsp;Baomin Dou,&nbsp;Yi Guo","doi":"10.1002/alz.14605","DOIUrl":"https://doi.org/10.1002/alz.14605","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Clinical studies have revealed a significant correlation between pain and neurodegenerative diseases, particularly Alzheimer's disease (AD). However, due to cognitive and speech impairments, AD patients, especially those in moderate to severe stages, are often overlooked in pain management. The challenges in obtaining pain-related information from this population exacerbate the issue. Although recent clinical research has increasingly recognized the comorbidity of AD and pain, the pathological alterations and interactive mechanisms underlying this relationship remain inadequately explored. This review provides a comprehensive analysis of the clinical features and pathological mechanisms of AD with and without pain comorbidity. It examines underlying processes, including neuroinflammation, peripheral-central immune interactions, and neurotransmitter dynamics. Furthermore, it highlights current pain assessment and management strategies in AD patients. By offering a theoretical framework, this review aims to support the development of effective pain management approaches and serve as a reference for clinical interventions targeting AD-associated pain.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Highlights</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>The comorbidity between AD and CP encompasses multiple interrelated biological pathways, such as neurodegeneration and inflammatory responses.</li>\u0000 \u0000 <li>The damage to neurons and synapses in AD patients influences the brain regions responsible for processing pain, thereby reducing the pain response.</li>\u0000 \u0000 <li>Neuroinflammation plays a vital role in the development of both AD and CP. Enhanced inflammatory responses have an impact on the CNS and promote sensitization.</li>\u0000 \u0000 <li>Common neurotransmitter alterations exist in the comorbidity of AD and CP, influencing cognition, emotion, and pain perception.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14605","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143481351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic exposure-wide framework leveraging machine learning to identify multidomain exposure factors and their joint influence on cognitive function: Evidence from a neurological cohort
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-25 DOI: 10.1002/alz.14624
Jingtao Wu, Bowen Yin, Rui Wen, Huanting Pei, Siqi Zhu, Jiaxin Zhao, Yanbing Li, Ming Yang, Yaoyu Hu, Qun Xu, Ang Li, Yuxia Ma

INTRODUCTION

Cognitive decline has become a growing public concern, yet large-scale exposure data identifying the contributing factors remain limited.

METHODS

We conducted an exposure-wide association study involving 1142 participants and 207 exposures, using machine learning to assess the relative contribution and joint effects of key factors. Cluster analysis and intervention simulation trials helped identify high-risk subpopulations and the potential benefits of targeted interventions.

RESULTS

In adjusted mixed models, the socioeconomic status domain emerged as the strongest predictor of longitudinal global cognitive score (β = 2.91, < 0.0001, q < 0.0001), while the dietary domain also played an important role in memory function. The cluster analysis found that the “unfavorable lifestyle” dominated phenotype was associated with the poorest cognitive outcomes. Simulation trials indicated that cognitive scores could improve by shifting individuals from unfavorable to favorable phenotypes.

DISCUSSION

Cognitive health requires multidomain interventions, particularly in the socioeconomic and dietary fields, and necessitates collaboration between government and individuals.

Highlights

  • The exposure-wide association study design, which assesses a broad range of exposures, is used to identify novel variables and understand their contributions to cognitive function.
  • The findings from the multidomain analysis indicate that socioeconomic status is the most significant contributor to global cognitive function, while diet plays the largest role in memory function.
  • Increasing the proportion of favorable phenotypes through multidomain interventions can significantly enhance public cognitive health.
{"title":"A systematic exposure-wide framework leveraging machine learning to identify multidomain exposure factors and their joint influence on cognitive function: Evidence from a neurological cohort","authors":"Jingtao Wu,&nbsp;Bowen Yin,&nbsp;Rui Wen,&nbsp;Huanting Pei,&nbsp;Siqi Zhu,&nbsp;Jiaxin Zhao,&nbsp;Yanbing Li,&nbsp;Ming Yang,&nbsp;Yaoyu Hu,&nbsp;Qun Xu,&nbsp;Ang Li,&nbsp;Yuxia Ma","doi":"10.1002/alz.14624","DOIUrl":"10.1002/alz.14624","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> INTRODUCTION</h3>\u0000 \u0000 <p>Cognitive decline has become a growing public concern, yet large-scale exposure data identifying the contributing factors remain limited.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> METHODS</h3>\u0000 \u0000 <p>We conducted an exposure-wide association study involving 1142 participants and 207 exposures, using machine learning to assess the relative contribution and joint effects of key factors. Cluster analysis and intervention simulation trials helped identify high-risk subpopulations and the potential benefits of targeted interventions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> RESULTS</h3>\u0000 \u0000 <p>In adjusted mixed models, the socioeconomic status domain emerged as the strongest predictor of longitudinal global cognitive score (<i>β</i> = 2.91, <i>p </i>&lt; 0.0001, <i>q</i> &lt; 0.0001), while the dietary domain also played an important role in memory function. The cluster analysis found that the “unfavorable lifestyle” dominated phenotype was associated with the poorest cognitive outcomes. Simulation trials indicated that cognitive scores could improve by shifting individuals from unfavorable to favorable phenotypes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> DISCUSSION</h3>\u0000 \u0000 <p>Cognitive health requires multidomain interventions, particularly in the socioeconomic and dietary fields, and necessitates collaboration between government and individuals.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Highlights</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>The exposure-wide association study design, which assesses a broad range of exposures, is used to identify novel variables and understand their contributions to cognitive function.</li>\u0000 \u0000 <li>The findings from the multidomain analysis indicate that socioeconomic status is the most significant contributor to global cognitive function, while diet plays the largest role in memory function.</li>\u0000 \u0000 <li>Increasing the proportion of favorable phenotypes through multidomain interventions can significantly enhance public cognitive health.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14624","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143486360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-25 DOI: 10.1002/alz.14618
Chuyao Huang, Zhenwen Wei, Ningxiang Zheng, Jingsi Yan, Jiayu Zhang, Xinyi Ye, Wei Zhao

Tauopathy is one of the pathological features of Alzheimer's disease and related dementias (ADRD). At present, there have been many studies on the formation, deposition, and intercellular transmission of tau in neurons and immune cells. The vasculature is an important component of the central nervous system. This review discusses the interaction between vasculature and tau in detail from three aspects. (1) The vascular risk factors (VRFs) discussed in this review include diabetes mellitus (DM), abnormal blood pressure (BP), and hypercholesterolemia. (2) In ADRD pathology, the hyperphosphorylation and deposition of tau interact with disrupted vasculature, such as different cells (endothelial cells, smooth muscular cells, and pericytes), the blood−brain barrier (BBB), and the cerebral lymphatic system. (3) The functions of vasculature are regulated by various signaling transductions. Endothelial nitric oxide synthase/nitric oxide, calcium signaling, Rho/Rho-associated coiled-coil containing Kinase, and receptors for advanced glycation end products are discussed in this review. Our findings indicate that the prevention and treatment of vascular health may be a potential target for ADRD combination therapy.

Highlights

  • Persistent VRFs increase early disruption of vascular mechanisms and are strongly associated with tau pathology in ADRD.
  • Cell dysfunction in the vasculature causes BBB leakage and drainage incapacity of the cerebral lymphatic system, which interacts with tau pathology.
  • Signaling molecules in the vasculature regulate vasodilation and contraction, angiogenesis, and CBF. Abnormal signaling transduction is related to tau hyperphosphorylation and deposition.
{"title":"The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias","authors":"Chuyao Huang,&nbsp;Zhenwen Wei,&nbsp;Ningxiang Zheng,&nbsp;Jingsi Yan,&nbsp;Jiayu Zhang,&nbsp;Xinyi Ye,&nbsp;Wei Zhao","doi":"10.1002/alz.14618","DOIUrl":"10.1002/alz.14618","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Tauopathy is one of the pathological features of Alzheimer's disease and related dementias (ADRD). At present, there have been many studies on the formation, deposition, and intercellular transmission of tau in neurons and immune cells. The vasculature is an important component of the central nervous system. This review discusses the interaction between vasculature and tau in detail from three aspects. (1) The vascular risk factors (VRFs) discussed in this review include diabetes mellitus (DM), abnormal blood pressure (BP), and hypercholesterolemia. (2) In ADRD pathology, the hyperphosphorylation and deposition of tau interact with disrupted vasculature, such as different cells (endothelial cells, smooth muscular cells, and pericytes), the blood−brain barrier (BBB), and the cerebral lymphatic system. (3) The functions of vasculature are regulated by various signaling transductions. Endothelial nitric oxide synthase/nitric oxide, calcium signaling, Rho/Rho-associated coiled-coil containing Kinase, and receptors for advanced glycation end products are discussed in this review. Our findings indicate that the prevention and treatment of vascular health may be a potential target for ADRD combination therapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Highlights</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>Persistent VRFs increase early disruption of vascular mechanisms and are strongly associated with tau pathology in ADRD.</li>\u0000 \u0000 <li>Cell dysfunction in the vasculature causes BBB leakage and drainage incapacity of the cerebral lymphatic system, which interacts with tau pathology.</li>\u0000 \u0000 <li>Signaling molecules in the vasculature regulate vasodilation and contraction, angiogenesis, and CBF. Abnormal signaling transduction is related to tau hyperphosphorylation and deposition.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14618","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143485875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to “Incidence of dementia in the German Heinz Nixdorf Recall study over 20 years”
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-25 DOI: 10.1002/alz.70008

Schramm S, Rinck C, Krizanovic N, et al. Incidence of dementia in the German Heinz Nixdorf Recall study over 20 years. Alzheimer's Dement. 2025;17(1):e70061. https://doi.org/10.1002/dad2.70061. PMID: 39822293; PMCID: PMC11736620.

The letter “M” of Prof Hermann's middle name has been lost. The name is Dirk M Hermann.

We apologize for this error.

{"title":"Correction to “Incidence of dementia in the German Heinz Nixdorf Recall study over 20 years”","authors":"","doi":"10.1002/alz.70008","DOIUrl":"10.1002/alz.70008","url":null,"abstract":"<p>Schramm S, Rinck C, Krizanovic N, et al. Incidence of dementia in the German Heinz Nixdorf Recall study over 20 years. <i>Alzheimer's Dement</i>. 2025;17(1):e70061. https://doi.org/10.1002/dad2.70061. PMID: 39822293; PMCID: PMC11736620.</p><p>The letter “M” of Prof Hermann's middle name has been lost. The name is Dirk M Hermann.</p><p>We apologize for this error.</p>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.70008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143485874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Nun Study: Insights from 30 years of aging and dementia research
IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-02-25 DOI: 10.1002/alz.14626
Kyra M. Clarke, Shahroo Etemadmoghadam, Benjamin Danner, Cole Corbett, Ali Ghaseminejad-Bandpey, Matthew Dopler, Julie Parker-Garza, Mohammad Alhneif, Sahana Babu, Oluwaseun B. Ogunbona, Angelique D. Gonzalez, Arash Salardini, Margaret E. Flanagan

The Nun Study is an iconic longitudinal study of aging and dementia on a cohort of 678 Catholic nuns from the School Sisters of Notre Dame. Participants consented to undergoing annual neuropsychological assessments, allowing researchers access to convent archives and medical records and post mortem brain donation. This study investigated the associations between epidemiological factors, cognitive function, and brain pathology. By examining published literature that reports on or utilizes Nun Study data, we provide an overview of its methodology and key findings, emphasizing its significant contributions to understanding cognitive impairment and related neuropathologies. Seminal findings on early-life factors affecting cognitive health, clinicopathological correlations, and apparent resistance and resilience to neuropathology are discussed. Decades of Nun Study research have made critical contributions to our understanding of Alzheimer's disease and related dementias and highlight continuing objectives for future research.

Highlights

  • The uniform lifestyles of participants minimized potential confounds of the study.
  • Early-life cognitive ability influenced late-life cognitive outcomes.
  • Some participants with AD pathology did not exhibit dementia.
  • Neuropathological comorbidities were common and increased the risk of dementia.
{"title":"The Nun Study: Insights from 30 years of aging and dementia research","authors":"Kyra M. Clarke,&nbsp;Shahroo Etemadmoghadam,&nbsp;Benjamin Danner,&nbsp;Cole Corbett,&nbsp;Ali Ghaseminejad-Bandpey,&nbsp;Matthew Dopler,&nbsp;Julie Parker-Garza,&nbsp;Mohammad Alhneif,&nbsp;Sahana Babu,&nbsp;Oluwaseun B. Ogunbona,&nbsp;Angelique D. Gonzalez,&nbsp;Arash Salardini,&nbsp;Margaret E. Flanagan","doi":"10.1002/alz.14626","DOIUrl":"https://doi.org/10.1002/alz.14626","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>The Nun Study is an iconic longitudinal study of aging and dementia on a cohort of 678 Catholic nuns from the School Sisters of Notre Dame. Participants consented to undergoing annual neuropsychological assessments, allowing researchers access to convent archives and medical records and <i>post mortem</i> brain donation. This study investigated the associations between epidemiological factors, cognitive function, and brain pathology. By examining published literature that reports on or utilizes Nun Study data, we provide an overview of its methodology and key findings, emphasizing its significant contributions to understanding cognitive impairment and related neuropathologies. Seminal findings on early-life factors affecting cognitive health, clinicopathological correlations, and apparent resistance and resilience to neuropathology are discussed. Decades of Nun Study research have made critical contributions to our understanding of Alzheimer's disease and related dementias and highlight continuing objectives for future research.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Highlights</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>The uniform lifestyles of participants minimized potential confounds of the study.</li>\u0000 \u0000 <li>Early-life cognitive ability influenced late-life cognitive outcomes.</li>\u0000 \u0000 <li>Some participants with AD pathology did not exhibit dementia.</li>\u0000 \u0000 <li>Neuropathological comorbidities were common and increased the risk of dementia.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14626","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143481350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Alzheimer's & Dementia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1